For instance, activating transcription factor 3 (ATF3) has been shown to promote ferroptosis and enhance cisplatin sensitivity in gastric cancer by inhibiting the Nrf2/Keap1/xCT pathway (Fu et al., 2021). Here, SLC7A11 is linked to gastric cancer.